Efficacy and Safety of Luseogliflozin (TS-071) in Japanese Children and Adolescents with Type 2 Diabetes Mellitus: A Multicenter, Randomized, Double-Masked, Placebo-Controlled Phase 3 Study.
Kikuchi T, Nakamura H, Umeuchi H, Kitajima I, Yamasaki H, Urakami T
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.